
Transpharmation delivers preclinical translational biology services to advance neuroscience drug programs. It uses robust animal models and cross-species data to generate clinically relevant evidence, including the world’s largest laboratory beagle colony for age-related and pain models, and it employs custom platforms and gold-standard models to support discovery and safety assessments. It operates as a B2B preclinical CRO focused on neuroscience and translational biology, integrating standard and specialized models to deliver actionable data for drug developers. Recent partnerships and acquisitions, including with Cykel AI and Saretius, indicate growth and ongoing capability expansion. The company aims to provide neuroscience-focused translational data to de-risk drug development.

Transpharmation delivers preclinical translational biology services to advance neuroscience drug programs. It uses robust animal models and cross-species data to generate clinically relevant evidence, including the world’s largest laboratory beagle colony for age-related and pain models, and it employs custom platforms and gold-standard models to support discovery and safety assessments. It operates as a B2B preclinical CRO focused on neuroscience and translational biology, integrating standard and specialized models to deliver actionable data for drug developers. Recent partnerships and acquisitions, including with Cykel AI and Saretius, indicate growth and ongoing capability expansion. The company aims to provide neuroscience-focused translational data to de-risk drug development.